Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NS-3623: a long-acting, reversible Cl conductance blocker for sickle cell disease

May 7, 2001

Novartis files for approval of Diovan for heart failure in several countries

May 4, 2001

New class of rilmenidine analogues with high selectivity for I1 receptors and hypotensive activity

May 4, 2001

Pfizer identifies and characterizes potent and selective NHE-1 inhibitor

May 3, 2001

Oral endothelin receptor antagonist achieves primary endpoint in phase III trial for PAH

May 3, 2001

New endothelin receptor antagonists useful for circulatory disorders

April 30, 2001

Vasogen plans trial of immune modulation therapy for PAD

April 30, 2001

Icos initiates phase III trial of Pafase for treatment of severe sepsis

April 27, 2001

Merck KGaA presents new PDE5 inhibitors and their uses

April 26, 2001

Medicure successfully completes phase I trial of MC-1; phase II studies planned

April 20, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026